Kolexia
Menguy Sandrine
Pharmacien
Institut de Cancérologie de la Loire Lucien Neuwirth
Saint-Priest-en-Jarez, France
18 Activités
36 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Leucémies Leucémie myéloïde Leucémie myéloïde chronique BCR-ABL positive Mycoses Leucémie aigüe myéloïde {{person.topmesh7.name}} {{person.topmesh8.name}} {{person.topmesh9.name}} {{person.topmesh10.name}}

Industries

AstraZeneca
1 collaboration(s)
Dernière en 2022
Janssen
1 collaboration(s)
Dernière en 2020
{{person.topindus3.name}}
{{person.topindus3.tot}} collaboration(s)
Dernière en {{person.topindus3.last}}
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

PHARM-LMC: Interest of PHARMaceutical Conciliation to Understand Drug Interactions, Phytotherapy, and Targeted Therapies in Chronic Myeloid Leukemia: PHARM-LMC Study
Essai Clinique (CHU Saint-Étienne)   09 janvier 2024
Evaluation of a safe infusion device on reducing occupational exposure of nurses to antineoplastic drugs: a comparative prospective study. Contamoins-1.
International archives of occupational and environmental health   17 mars 2021
How human activity impacted manufacturing non-compliances: A multivariate analysis in a centralized cytotoxic preparation unit.
Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners   17 novembre 2020
Evaluation of the use of Complementary and Alternative Medicine associated with a risk of drugs interactions in cancer patients
Abstracts of the Annual Meeting of French Society of Pharmacology and Therapeutics, and INSERM Clinical Research Centers (CIC) Meeting, 12–14 June 2019, Lyon, France   05 juin 2019
Menguy-Sandrine-Pharmacien-Institut de cancérologie Lucien Neuwirth ...
Gestions Hospitalières   01 février 2017
Impact of fluconazole versus posaconazole prophylaxis on the incidence of fungal infections in patients receiving induction chemotherapy for acute myeloid leukemia.
Biomedical journal   13 décembre 2016
{{person.lastact7.name}}
{{person.lastact7.jour}}   {{person.lastact7.date}}
{{person.lastact8.name}}
{{person.lastact8.jour}}   {{person.lastact8.date}}
{{person.lastact9.name}}
{{person.lastact9.jour}}   {{person.lastact9.date}}
{{person.lastact10.name}}
{{person.lastact10.jour}}   {{person.lastact10.date}}